The Odds of an Oct. 28 Fed Rate Hike Are Soaring, and President Donald Trump Is, in Part, to Blame

The FOMC raised the federal-funds target rate 25bps to 3.75%-4.00% on Sept. 16, and CME FedWatch pricing for another 25bp hike by Oct. 28 surged to 57.6% from 6.6% on Aug. 19. Persistent inflation is attributed to 10%-12.5% tariffs on imports, fuel-price pressure after the Iran conflict disrupted Strait of Hormuz traffic, and higher AI hardware costs; U.S. diesel prices reached a record $6.45 per gallon. Ten- and 30-year Treasury yields are at 19-year highs amid inflation concerns and U.S. debt above $40 trillion, reinforcing expectations for further Fed tightening and pressuring equities.

Analysis

The relevant transmission channel is not the first hike but a higher terminal-rate and term-premium regime. Equities have not yet fully reconciled elevated nominal growth with a discount rate that compresses long-duration multiples; QQQ, XLRE and XLU remain most exposed if real yields—not merely inflation breakevens—continue higher. Banks are not a clean winner: a steeper curve helps asset yields, but rising funding costs, unrealized securities losses and eventual credit normalization can overwhelm NIM expansion for regionals.

NVDA and the AI supply chain have a more nuanced setup than the headline implies. Pricing power can sustain near-term revenue and gross margins, but the 6-18 month constraint is the hyperscaler financing equation: higher debt costs raise the required return on data-center capex and make marginal GPU deployments less economic. The first evidence of a turn would be capex guidance moderation from MSFT, AMZN, GOOGL or META, rather than a near-term slowdown in chip orders; that would pressure the highest-duration AI infrastructure names disproportionately.

CME is a comparatively direct beneficiary of persistent uncertainty through interest-rate and energy derivatives volumes, but the equity is not a pure rates trade: sustained volatility must convert into ADV and open-interest growth rather than a short-lived event spike. The contrarian risk is that markets are extrapolating policy tightening while supply shocks fade; a rapid decline in oil and freight measures could pull breakevens lower even as nominal yields remain high, producing a relief rally in duration-sensitive equities. Distinguish that outcome from a true disinflationary slowdown, which would be bearish for cyclicals and credit simultaneously.

Key Decisions for Investors

• Initiate a 1-3 month relative-value hedge: long CME versus short QQQ in equal beta-weighted dollars. CME has operating leverage to sustained rate/energy volatility, while QQQ carries the clearest multiple sensitivity to further real-yield repricing; exit if 10-year real yields fall 40-50bp from current levels or CME ADV fails to improve over the next monthly data release.
• Favor XLE over XLRE for the next 1-3 months, sized modestly. The pair captures energy cash-flow resilience versus refinancing and cap-rate pressure in REITs; take profit if oil backwardation collapses or a credible supply-normalization catalyst drives front-month crude down more than 15%.
• Do not add directional NVDA exposure solely on nominal pricing strength. Maintain existing exposure but buy 3-6 month downside protection or reduce on strength if hyperscaler aggregate capex guidance decelerates below current run-rate expectations; the falsifier is continued upward capex revisions alongside stable GPU lead times, which would validate a renewed long.
• Use TLT puts or a short TLT position as a tactical 30-60 day portfolio hedge only while long-end yields are rising alongside inflation compensation. Cover if yields rise primarily through real-growth deterioration and high-yield spreads widen materially, since that regime shifts the trade from inflation hedge to recession risk.
• Monitor CME monthly volume statistics and Fed-funds/OIS implied volatility rather than headline rate probabilities. Upgrade CME to a standalone long only if elevated short-rate volatility persists through two consecutive reporting periods; otherwise the earnings benefit is likely too transient to justify multiple expansion.